|
Summaries of Product Characteristics (SPC) for Human medicinal products
The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.
Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.
The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.
The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.
Summaries of Product Characteristics 121 - 150 of 460 |
|
|
Package leaflet | Status for supply | Name of the medicinal product |
PL
|
Resepti
|
Albuman 200 g-l infuusioneste, liuos SPC 2021-12-17
|
PL
|
Resepti
|
Albuman 40 g-l infuusioneste, liuos SPC 2021-12-17
|
PL
|
Resepti
|
Albumin Baxalta 200 g-l infuusioneste, liuos SPC 2022-01-14
|
PL
|
Resepti
|
Albumin Baxalta 50 g-l infuusioneste, liuos SPC 2022-01-14
|
PL
|
Resepti
|
Albumin Behring 200 g-l, infuusioneste, liuos SPC 2021-11-23
|
PL
|
Resepti
|
Albunorm 200 g-l infuusioneste, liuos SPC 2022-09-07
|
PL
|
Resepti
|
Albunorm 250 g-l infuusioneste, liuos SPC 2022-09-07
|
PL
|
Resepti
|
Albunorm 40 g-l infuusioneste, liuos SPC 2022-09-07
|
PL
|
Resepti
|
Albunorm 50 g-l infuusioneste, liuos SPC 2022-09-07
|
PL
|
Resepti
|
Alburex 200 g-l infuusioneste, liuos SPC 2021-06-30
|
PL
|
Resepti
|
Alburex 50 g-l infuusioneste, liuos SPC 2023-09-28
|
PL
|
Resepti
|
Albutein 200 g-l infuusioneste, liuos SPC 2023-12-15
|
PL
|
Resepti
|
Albutein 50 g-l infuusioneste, liuos SPC 2023-12-15
|
|
|
European Medicines Agency's website: Aldara - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Aldurazyme - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Alecensa - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Alendronat ratiopharm 70 mg tabletti, kalvopäällysteinen SPC 2023-08-29
|
PL
|
Resepti
|
Alendronat Sandoz 70 mg tabletti SPC 2020-01-22
|
PL
|
Resepti
|
Alendronat Viatris 70 mg tabletti SPC 2023-05-24
|
PL
|
Resepti
|
Alfacalcidol Orifarm 0,25 mikrog, 0,5 mikrog, 1 mikrog kapseli, pehmeä SPC 2022-02-11
|
PL
|
Resepti
|
Alfacalcidol Strides 0,25 mikrog, 0,5 mikrog, 1 mikrog kapseli, pehmeä SPC 2024-01-03
|
PL
|
Resepti
|
Alfentanil Hameln 0.5 mg/ml injektioneste, liuos, SPC 2022-12-12.doc
|
PL
|
Resepti
|
Alfentanil Kalceks 0.5 mg-ml injektio-infuusioneste, liuos SPC 2023-08-23
|
PL
|
Resepti
|
Alfuzosin hydrochlorid ratiopharm 10 mg depottabletti SPC 2024-04-26
|
PL
|
Resepti
|
Alfuzosin hydrochloride Orion 10 mg depottabletti SPC 2023-01-09
|
|
|
European Medicines Agency's website: ALIMTA - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Alitretinoin Orifarm 10 mg, 20 mg kapseli, pehmeä SCP 2020-04-03
|
PL
|
Resepti
|
Alkacit 10 mEq säädellysti vapauttava tabletti SPC 2024-06-12
|
PL
|
Resepti
|
Alkeran 2 mg tabletti, kalvopäällysteinen SPC 2022-06-16
|
|
|
European Medicines Agency's website: Alkindi - EMA: EPAR PI
Finnish Swedish
|
|
| |